General
Preferred name
NOREPINEPHRINE
Synonyms
NOREPINEPHRINE TARTRATE ()
Norepinephrine Bitartrate ()
L(-)-Norepinephrine bitartrate ()
noradrenaline ()
Aktamin ()
Arterenol ()
Levonor ()
Levonoradrenaline ()
Levophed ()
Nor-Epirenan ()
Norepinephrine bitartrate monohydrate ()
Noradrenaline bitartrate monohydrate ()
Noradrenaline bitartrate ()
noradrenaline hydrochloride ()
Adrenor ()
Norepinephrine (hydrochloride) ()
Norepinephrine (bitartrate monohydrate) ()
(-)-Norepinephrine ()
NOREPINEPHRINE BITARTRATE ()
Levarterenol (hydrochloride) ()
L-Noradrenaline (hydrochloride) ()
Levarterenol ()
L-Noradrenaline ()
Levarterenol (bitartrate monohydrate) ()
L-Noradrenaline (bitartrate monohydrate) ()
(?)-Norepinephrine ()
Arterenol, Levarterenol, L-Noradrenaline ()
Norepinephrine hydrochloride ()
(-)-noradrenaline ()
R-norepinephrine ()
Nor adrenalin ()
NSC-757246 ()
Noradrenaline ()
Levarterenol Bitartrate ()
Arterenol, tartrate, monohydrate ()
Noradrenaline tartrate ()
Binodrenal ()
Norepinephrine bitartrate in 5% dextrose ()
Noradrenaline (as tartrate) ()
NSC-169106 ()
Norepinephrine d-bitartrate ()
(-)-Norepinephrine (bitartrate hydrate) ()
P&D ID
PD010223
CAS
69815-49-2
51-41-2
108341-18-0
51-40-1
138-65-8
4899-05-2
55-27-6
329-56-6
Tags
natural product
drug
available
Approved by
FDA
First approval
1950
Drug Status
approved
Drug indication
Sepsis
Adrenergic (vasoconstrictor)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Marketed formulations may contain noradrenaline tartrate (PubChem CID 25127519). (GtoPdb)
DESCRIPTION Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally active (Tocris Bioactive Compound Library)
DESCRIPTION Adrenergic neurotransmitter; vasoconstrictor (LOPAC library)
DESCRIPTION Noradrenaline bitartrate monohydrate is a direct alpha-adrenergic receptors stimulator. Noradrenaline modulates the gain of evoked activity, especially in sensory areas. (BOC Sciences Bioactive Compounds)
DESCRIPTION Adrenal medullary stress hormone, mediator of the fight-or-flight response; and the primary neurotransmitter in the post-ganglionic sympathetic (adrenergic) nervous system. (BOC Sciences Bioactive Compounds)
DESCRIPTION Norepinephrine is the US name for noradrenaline, a catecholamine with multiple roles including as a hormone and a neurotransmitter. It performs its action by being released into the synaptic cleft, where it acts on adrenergic receptors, followed by the signal termination, either by degradation of norepinephrine, or by uptake by surrounding cells. (BOC Sciences Bioactive Compounds)
Cell lines
0
Organisms
2
Compound Sets
31
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
ZINC Tool Compounds
External IDs
97
Properties
(calculated by RDKit )
Molecular Weight
169.07
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
0.09
TPSA
86.71
Fraction CSP3
0.25
Chiral centers
1.0
Largest ring
6.0
QED
0.47
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
alpha, beta1
Pathway
Proteases/Proteasome
GPCR/G protein
Neuroscience
Autophagy
Metabolic Enzyme/Protease
Neuronal Signaling
Target
MMP-2
MMP-9
??2A adrenoceptor
??1 adrenoceptor
??1-adrenergic receptor
??1-selective adrenergic receptor
Adrenergic Receptor
¦Â1-adrenergic receptor
ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2
Endogenous Metabolite
Primary Target
Non-selective Adrenergic ? Receptors
MOA
Adrenergic Receptor agonist
Agonist
MMP activator
alpha-Adrenoceptor Agonists
beta-Adrenoceptor Agonists
"alpha-Adrenoceptor Agonists
beta-Adrenoceptor Agonists"
Member status
member
Indication
hypertension, urticaria, headache, seasonal affective disorder
Disease Area
cardiology, allergy, neurology/psychiatry
Therapeutic Class
Vasoconstrictor Agents
Solubility
Soluble in Methanol (Slightly), Water (Sparingly)
Soluble in Aqueous Acid (Slightly), DMSO (Slightly)
Source data